Skip Nav Destination
First Edition
Research Article February 28 2025
Estrogen Receptor Βeta Stimulation as a Possible Novel Therapeutic Target for Cutaneous T-Cell Lymphoma
Deniz Özistanbullu,Raphael Wilhelm,Gabi Reichenbach,Monika Doll,Karola Bahrami,Nadja Zöller,Frank Schnütgen,Anke König,Theresia Scheller,Lars Winkler,Pascal Spahn,Manuel Jaeger,Jan P. Nicolay,Josef M. Pfeilschifter,Bastian Schilling,Roland Kaufmann,Alexander Koch,Stefan Kippenberger,Johannes Kleemann,Markus Meissner
Research Article February 28 2025
BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice
Research Article February 26 2025
Characterization and Treatment Outcomes of Malignant Histiocytoses in a Retrospective Series of 141 Cases in France
Camille Bigenwald, Dr,Damien Roos-Weil,Arnaud Pages,Zofia Hélias-Rodzewicz,Christiane Copie-Bergman,Marzieh Nashvi,Pierre khneisser,Marie-Cécile Parrens,Alexandra Traverse-Glehen,Isabelle Ray-Coquard,Loic Ysebaert,Tony Marchand,Jérome Razanamahery,Frédéric Charlotte,Antoine Neel,Gandhi Damaj,Jeremie Dion,Eve Marie Nazal-Traissac,Stéphanie Tardy,Geraldine Salmeron,Hélène Monjanel,Ahmed Iobaih,Sebastien Heritier,Julien Haroche, MD, PhD,Jean Donadieu,Jean-Francois Emile
Letter February 24 2025
Gastrointestinal toxicity of Gemtuzumab Ozogamicin: Real-life data from the AMLCG, SAL and CELL study groups
Ricarda Knabe,Philippe Muller,Christoph Schliemann,Maher Hanoun,Julia Marie Unglaub,Barbora Weinbergerová,Jiri Mayer,Carolin Krekeler,Stefan W Krause,Martin Kaufmann,Sabrina Kraus,Björn Steffen,Franziska Modemann,Marion Subklewe,Veit L. Bücklein,Wolfgang G. Kunz,Martina Rudelius,Michael von Bergwelt-Baildon,Katja Gutmair,Eva Hoster,Tobias Herold,Christoph Röllig,Karsten Spiekermann
Research Article February 21 2025
Improved survival with model-based dosing of anti-thymocyte globulin in pediatric hematopoietic cell transplantation
Rick Admiraal,Stefan Nierkens,Marc B Bierings,Mirjam E Belderbos,Alwin D. R. Huitema,Robbert GM Bredius,Yilin Jiang,Kevin J. Curran,Andromachi Scaradavou,Maria I. Cancio,Elizabeth Klein,Wouter J Kollen,Dorine Bresters,Friso G. Calkoen,Birgitta Versluijs,C. Michel Zwaan,Jaap Jan Boelens,Caroline A. Lindemans
Research Article February 21 2025
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa
William Frank Mawalla, Dr,Caroline Achola,Hadijah Nabalende,Isaac Otim,Ismail Legason,Martin David Ogwang,Pamella Mwa Aol, PA,Godlove William Sandi,Hadija Mwamtemi,Salama Omari Mahawi, MD,Elifuraha Mkwizu,Philomena G Lyamuya,Jacqueline Peter Kamanga,Kristin M.S. Schroeder,Paul Shadrack Ntemi,Clara Claudius Chamba,Dimitris V. Vavoulis,Liz Morrell,Lulu Fred Chirande,Anna Schuh
Research Article February 21 2025
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: Focus on the very early period and Omicron era
Letter February 21 2025
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Letter February 20 2025
Diffuse Lung Involvement as a Rare Presentation of Systemic AL Amyloidosis: A Retrospective Cohort Study
Research Article February 19 2025
Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in B cells
Research Article February 19 2025
Improved Outcome and Therapeutic Directions in Pediatric Therapy-related AML: Recommendations by the AML-BFM Study Group
Letter February 19 2025
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
Reid Shaw,James J. Yoon,Hannah Johnston,Marta B. Davidson,Alexa J. Siddon,Rory M. Shallis,Evan Chris Chen,Madelyn Burkart,Timothy S. Oh,Sunil Girish Iyer,Ellen Madarang,Chandrasekar Muthiah,Joshua Kassner,Raajit K. Rampal,Guru Subramanian Guru Murthy,Terrence J Bradley,Yasmin Abaza,Jacqueline S. Garcia,Vikas Gupta,Kristen M. Pettit,Olatoyosi Odenike,Anand A Patel
Research Article February 14 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T cell lymphoma
Research Article February 14 2025
In Vitro Studies of Human Erythropoiesis Using a 3D Silk-Based Bone Marrow Model That Generates Erythroblastic Islands
Research Article February 12 2025
Late-Onset Telomere Biology Disorders: Clinical Insights and Treatment Outcomes from a Retrospective Registry Cohort
Mareike Tometten,Fabian Beier,Martin Kirschner,Yannic Schumacher,Jeanette Walter,Margherita Vieri,Kim Kricheldorf,Alexander Röth,Uwe Platzbecker,Markus P. Radsak,Phillippe Schafhausen,Selim Corbacioglu,Britta Höchsmann,Stefan Balabanov,Claas Heinrich Hinze,Jörg Chromik,Michael Heuser,Michael Kreuter,Marcin W Wlodarski,Miriam Elbracht,Ingo Kurth,Steffen Koschmieder,Jens Peter Panse,Robert Meyer,Tim H. Brümmendorf
Research Article February 12 2025
Mitigating T-Cell Mitochondrial Dysfunction in CLL to Augment CAR T-Cell Therapy: Evaluation in an Immunocompetent Model
Research Article February 10 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in nonhuman primates
Review Article February 6 2025
FITNESS ASSESSMENT IN ACUTE MYELOID LEUKEMIA: RECOMMENDATIONS FROM AN EXPERT PANEL ON BEHALF OF EUROPEAN LEUKEMIA NET
Adriano Venditti,Raffaele Palmieri,Luca Maurillo,Christoph Röllig,Agnieszka Wierzbowska,David C. de Leeuw,Fabio Efficace,Antonio Curti,Lok Lam Ngai,Jesse M. Tettero,Lionel Adès,Antonio M Almeida,Lars Bullinger,Mike Dennis,Jordi Esteve,Felicetto Ferrara,Michael Heuser,Gerwin A Huls,Michael Lübbert,Priyanka Mehta,Pau Montesinos,Thomas Pabst,Christian Récher,Giuseppe Rossi,Nigel H. Russell,Jorge Sierra,Reinhard Stauder,Norbert Vey,Roland B. Walter,Eunice S Wang,Samantha Nier,Carolina Garcez Martins,Gert J Ossenkoppele
Research Article February 5 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a Phase II study
Research Article February 5 2025
Intermediate-Dose Post-Transplantation Cyclophosphamide for Myeloablative HLA-Haploidentical Bone Marrow Transplantation
Mustafa A. Hyder,Dimana Dimitrova,Ruby Sabina,Ashley DeVries,Jeannine S. McCune,Meredith J. McAdams,Francis A. Flomerfelt,Christi McKeown,Jennifer L. Sadler,Amy Chai,Thomas E. Hughes,Scott Napier,Anita Stokes,Jennifer Sponaugle,Kamil Rechache,Mark J Parta,Jennifer Cuellar-Rodriguez,William D. Figg,Hyoyoung Choo-Wosoba,Seth M. Steinberg,Jennifer A. Kanakry,Christopher G. Kanakry
Research Article February 5 2025
Glucagon-Like Peptide 1 Receptor Agonists and Venous Thromboembolism in Type 2 Diabetes: A Target Trial Emulation
Letter February 5 2025
Immune-aging is linked to clinical malignancy, racial ancestry and vaccine responses in myeloma
Research Article February 4 2025
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy
Paola Lanuti, PhD,Francesco Guardalupi,Giulia Corradi, PhD,Rosalba Florio, PhD,Davide Brocco, MD, PhD,Serena Veschi, PhD,Elsa Pennese, MD,Domenico De Bellis, PhD student,Francesca D'Ascanio, PhD Student,Anna Piro, PhD Student,Laura De Lellis, PhD,Pasquale Simeone,Maria Concetta Cufaro,Serena Pilato, PhD,Isabella D'Amario, PhD student,Ida Villanova, PhD,Barbara Di Francesco, PhD,Lucia Di Re, PhD Student,Fabio Verginelli, PhD,Damiana Pieragostino,Pressede Salutari, MD,Fabrizia Colasante, MD,Annalisa Natale, MD,Maria Vittoria Mattoli, MD,Simone Vespa,Antonella Fontana, PhD,Raffaella Giancola, MD, PhD,Bianca Fabi, MD,Stefano Baldoni,Stella Santarone,Francesco Restuccia,Nicola Tinari, MD, PhD,Piero Del Boccio,Alessandro Cama, PhD, MD,Mauro Di Ianni
Research Article January 30 2025
Impact of Vein-to-vein Time in Patients With R/R LBCL Treated With Axicabtagene Ciloleucel
Frederick L Locke,Tanya Siddiqi,Caron A. Jacobson,Sarah Nikiforow,Sairah Ahmed,David B Miklos,Yi Lin,Matthew A Lunning,Brian T. Hill,Armin Ghobadi,Zhen-Huan Hu,Michael T. Hemmer,Michael J Zoratti,Suresh Vunnum,Jonathan Tsang,Clare Spooner,Harry Smith,Christine Fu,Anik R Patel,Harry Miao,Shilpa A. Shahani,Debbie L. Mirjah,Hairong Xu,Marcelo C. Pasquini
Research Article January 28 2025
Outcome of high-grade B-cell lymphoma compared to other large B-cell lymphoma after CAR-T rescue. A DESCAR-T LYSA study
Xavier Phina-Ziebin,Emmanuel Bachy,Francois-Xavier Gros,Roberta Di Blasi,Charles Herbaux,Jacques Olivier Bay,Sylvain Carras,Pierre Bories,Olivier Casasnovas,Fabrice Jardin,Franck Morschhauser,Blandine Guffroy,Mohamad Mohty,Elodie Gat,Julien Calvani,Marie-Cécile Parrens,Elsa Poullot,Alexandra Traverse-Glehen,Louise Roulin
Research Article January 24 2025
Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation period
Research Article January 24 2025
TP53 Mutant Variant Allele Frequency and Cytogenetics Determine Prognostic Groups in MDS/AML for Transplantation
Research Article January 18 2025
PRMT5 Inhibition Reduces Hyperinflammation in a Murine Model of Secondary Hemophagocytic Lymphohistiocytosis (HLH)
Fiona Brown-Burke,Rachel Saadey,Hsiao-Yin Charlene Charlene Mao,Paola Marra,Eric Brooks,Alexa Wandtke,Ian Hout,Sydney Leon,Archisha Sharma,Aneeq Yasin,Taylor Cash,Elshafa Hassan Ahmed,Ethan James Baiocchi,Stephanie Scarlett Finoti,Xiaoli Zhang,Neha Bhagwat,Kris Vaddi,Peggy Scherle,Anna Mozhenkova,Ikbale El-Ayachi,Austin D. Schenk,Shelby L. Sloan,Kaylee Whitman,JoBeth Helmig-Mason,Sheldon Steyn,Haley L. Klimaszewski,Jessica Weist,Christoph Weigel,Shirsha Koirala,Lapo Alinari,Katiri Snyder,Parvathi Ranganathan,Chia-Jo Chen,Michael B. Jordan,Robert A. Baiocchi,Polina Shindiapina
Research Article January 18 2025
Definitions and use of tumour bulk in phase 3 lymphoma trials: a comprehensive literature review
Research Article January 16 2025
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL
Ibrahim Aldoss,Shanpeng Li,Jianying Zhang,Mary C Clark,Vaibhav Agrawal,Hoda Pourhassan,Paul B Koller,Ahmed Aribi,Haris Ali,Amanda Blackmon,Salman Otoukesh,Karamjeet S. Sandhu,Brian J. Ball,Shukaib Arslan,Andrew S. Artz,Idoroenyi Amanam,Monzr M. Al Malki,Amandeep Salhotra,Tibor J Kovacsovics,Lindsey A Murphy,Michelle Afkhami,Dat Ngo,Jose Tinajero,Zhaohui Gu,Pamela S. Becker,Ryotaro Nakamura,Anthony S. Stein,Guido Marcucci,Stephen J. Forman,Vinod A. Pullarkat
Research Article January 14 2025
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
Research Article January 7 2025
Maximum Tumor Diameter is Associated with Relapse Risk in Limited-Stage Hodgkin Lymphoma: An International Study
Research Article December 11 2024
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
Evgenii Shumilov,Rebecca Wurm-Kuczera,Andrea Kerkhoff,Meng Wang,Thomas Melchardt,Udo Holtick,Ulrike Bacher,Philipp B. Staber,Paolo Mazzeo,Corinna Leng,David Böckle,Alexander Sebastian Hölscher,Joseph Kauer,Natalia Rotter,Vladan Vucinic,Jakob D. Rudzki,David Nachbaur,Veit L. Bücklein,Ulf Schnetzke,Isabelle Krämer,Kai Wille,Alexander Hasse,Bastian von Tresckow,Mathias Hänel,Christian Koenecke,Giuliano Filippini Velazquez,Andreas Viardot,Christoph Schmid,Lorenz Thurner,Dominik Wolf,Marion Subklewe,Martin Dreyling,Peter Dreger,Sascha Dietrich,Ulrich Keller,Ulrich Jaeger,Richard Greil,Thomas Pabst,Georg Lenz,Björn Chapuy